Quetiapine Fumarate
Generic Name: quetiapine fumarate
Brand Names:
Quetiapine Fumarate
Quetiapine fumarate is an atypical antipsychotic medication available in tablet form for the treatment of schizophrenia and bipolar disorder.
Overview
Quetiapine fumarate is an atypical antipsychotic medication available in tablet form for the treatment of schizophrenia and bipolar disorder.
Uses
Treatment of schizophrenia, bipolar I disorder manic episodes, and bipolar disorder depressive episodes in specified age groups.
Dosage
Initial doses vary by indication (25-50 mg). Recommended dose ranges from 150-800 mg/day depending on condition. Maximum dose up to 800 mg/day.
Side Effects
Most common in adults: somnolence, dry mouth, dizziness, constipation, and weight gain. Metabolic changes including hyperglycemia and dyslipidemia may occur.
Warnings
Increased mortality in elderly patients with dementia-related psychosis. Suicidal thoughts and behaviors risk, especially in young adults. Cerebrovascular adverse reactions. Neuroleptic malignant syndrome risk. Metabolic changes. Tardive dyskinesia. Orthostatic hypotension. Contraindicated in patients with known hypersensitivity to quetiapine.
Frequently Asked Questions
What is Quetiapine Fumarate used for?▼
Treatment of schizophrenia, bipolar I disorder manic episodes, and bipolar disorder depressive episodes in specified age groups.
What are the side effects of Quetiapine Fumarate?▼
Most common in adults: somnolence, dry mouth, dizziness, constipation, and weight gain. Metabolic changes including hyperglycemia and dyslipidemia may occur.
What are the important warnings for Quetiapine Fumarate?▼
Increased mortality in elderly patients with dementia-related psychosis. Suicidal thoughts and behaviors risk, especially in young adults. Cerebrovascular adverse reactions. Neuroleptic malignant syndrome risk. Metabolic changes. Tardive dyskinesia. Orthostatic hypotension. Contraindicated in patients with known hypersensitivity to quetiapine.
Related Medications
Certolizumab Pegol
certolizumab pegol
Tumor Necrosis Factor Blocker [EPC]
11 DESCRIPTION Certolizumab pegol is a TNF blocker. CIMZIA is a recombinant, humanized antibody Fab' fragment, with specificity for human tumor necrosis factor alpha (TNFα), conjugated to an approximately 40kDa polyethylene glycol (PEG2MAL40K). The Fab' fragment is manufactured in E. coli and is subsequently subjected to purification and conjugation to PEG2MAL40K, to generate certolizumab pegol.
Bacitracin,neomycin,polymxin, Pramoxine
bacitracin,neomycin,polymxin, pramoxine
Purpose First Aid Antibiotic
Acetaminophen Dextromethorphan Hbr Phenylephrine Hci Doxylaminesucinate
acetaminophen dextromethorphan hbr phenylephrine hci doxylaminesucinate
Purposes for Day Time Pain reliever/fever reducer Cough suppressant Nasal decongestant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.